SOFIE @sofiebio

We are dedicated to improving patient outcomes by developing, supplying and delivering molecular diagnostics and therapeutics (theranostics). sofie.com Dulles, VA Joined April 2010

Tweets

908
Followers

562
Following

802
Likes

1K

ImaginAbInc @ImaginAbInc

3 years ago

In January, we launched our iPREDICT clinical trial globally in the US, Australia, and Europe. We are proud to announce the first patient dosed in Australia. Read more here: imaginab.com/news-events/ne… #Australiabiotech #immunotherapy #immunooncology #clinicaltrials

0 2 5 0 0

Download Image

SOFIE @sofiebio

3 years ago

linkedin.com/company/icpo-i…

0 0 3 0 0

Download Image

Diane M. Simeone, MD @MadameSurgeon

3 years ago

Very excited to test the ability of a novel molecular imaging agent targeting fibroblast activated protein (FAP) to pick up pancreatic cancer!” @sofie @ElcinZan @nyulangone ⁦@Perlmutter_CC⁩ #imagingpancreaticcancer prnewswire.com/news-releases/…

0 2 5 0 0

FSMN @faststocknewss

3 years ago

Eisai Co. and partner Biogen Inc. said their Alzheimer’s drug lecanemab slowed the disease, becoming the first medicine to clearly blunt the progression of the most common type of dementia in a final-phase trial $BIIB

2 15 56 0 1

JNM @JournalofNucMed

3 years ago

Read the FDA's reasoning and remember that @NCCN and @SNM_MI guidelines support the use of other validated and FDA-approved imaging probes for PLUVICTO treatment stratification. ow.ly/i7uQ50JSg9o #PrecisionMedicine #NucMed #ProstateCancer

2 7 11 0 0

WMIS WMIC @WMISWMIC

3 years ago

This is your last week to submit an abstract for WMIC! Submit by July 15th, 2022. Present your science in Miami and don't forget to book your hotel: wmis.org/wmic1/

0 9 9 0 0

Download Image

Clinical Nuclear Medicine @ClinNuclearMed

3 years ago

Current Issue: Fibrous Dysplasia Mimicking Skeletal Metastasis on 68Ga-FAPI PET Imaging dlvr.it/STN0Dh

0 10 19 0 3

Download Image

SOFIE @sofiebio

3 years ago

FAP session at Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting attracts packed audience sofie.com/2022/06/22/fap…

0 0 1 0 0

Sara Harsini @sara_harsini

3 years ago

Thanks @SNM_MI for the 2022 Alavi-Mandell award for this @JournalofNucMed publication. Recognition goes to all authors. #PSMA #ProstateCancer #nuclearmedicine snmmi.org/AboutSNMMI/Con…

4 8 39 0 2

SOFIE @sofiebio

3 years ago

How perfect. Dr Gambhir would be proud.

SNMMI @SNM_MI

3 years ago

How perfect. Dr Gambhir would be proud.

1 12 73 0 0

Download Image

0 0 5 0 0

Tom @petctimaging

3 years ago

Impact of 18F-DCFPyL PET on Staging and Treatment of Unfavorable Intermediate or High-Risk Prostate Cancer dlvr.it/SRC7Rq

0 1 0 0 0

JNM @JournalofNucMed

3 years ago

O. Sartor discusses the role of PSMA PET/CT for selecting patients for radioligand therapy. Thoughts? Please comment! ow.ly/aIhI50Jk05n #MedicalImaging #PETCT #ProstateCancer @sartor_oliver

0 6 17 0 0

Michael Hofman @DrMHofman

3 years ago

Predictors and Real-World Use of Prostate-Specific Radioligand Therapy: PSMA and Beyond @ASCO Education Book #ASCO22 ascopubs.org/doi/full/10.12… @DrAGafita @LouiseKostos @CalaisJeremie @pros_tic

1 21 66 0 3

Download Image

WMIS WIMIN @WIMIN_WMIS

3 years ago

We invite all WMIC 2022 attendees to fill out our pre-conference survey! ✨We want your input and feedback on WIMIN events you'd like to see at the upcoming WMIC conference. Fill out a survey & have a chance to win a $25 Amazon gift cards✨ surveymonkey.ca/r/YCRVYJT @WMISWMIC

0 4 4 0 0

Download Image

Tom Cohen @tomcohenuk

3 years ago

What are the three pillars of survival for a drug in development? Find out how the pioneering ImmunoPET technology works. @ImaginAbInc speaks to @OGConferences at our In Vivo imaging discussion group. #OGcollab oxfordglobal.co.uk/resources/bett…

1 2 6 0 0

David Lewis @DavidYLewis

3 years ago

Impressive and inspiring talk by Jason Lewis @LewisLabMSKCC at the @CRUK_BI today. Jason gave us an excellent vision of the future for #PET imaging and #theranostics. Phenomenal data.

3 4 51 0 0

Download Image

Thomas Hope @thomashopemd

3 years ago

Also great to see 177Lu-PSMA-617 added to the NCCN guidelines. As expected post-chemo and post-ARTT. Nice speedy updates by the NCCN panel. #PSMARLT bit.ly/3LkJV2v

3 15 52 0 2

Download Image

Thomas Hope @thomashopemd

3 years ago

Glad to see that the NCCN agrees that either 18F-DCFPyL or 68Ga-PSMA-11 should be used for selection of patients for 177Lu-PSMA-617 radioligand therapy. Hopefully we can put this issue to rest as soon as possible! #PSMAPET - bit.ly/3LkJV2v